• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Complications of Chickenpox

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 2 No 6
Volume 2
Issue 6

After several days of suffering fever, headache, and malaise, a 17-year-old boy noticed a rash developing over much of his body. He sought medical attention and was admitted to the hospital.

After several days of suffering fever, headache, and malaise, a 17-year-old boy noticed a rash developing over much of his body. He sought medical attention and was admitted to the hospital.

The rash consisted of diffuse, irregularly scattered red bumps and small blisters (A and B). The patient reported no personal history of chickenpox and denied recent exposure to the disease. Chickenpox, caused by the varicella-zoster virus, became the working diagnosis.

A few hours after the initial examination, the patient complained of severe respiratory distress; assisted ventilation was initiated. Pulmonary edema was noted on the chest film (C). Bone marrow failure and hepatitis developed as well. Biopsy specimens were obtained from lesions on the chest (D), and culture confirmed the diagnosis of chickenpox. Blood cultures were negative and bacterial sepsis was not suspected.

These uncommon but serious complications of chickenpox may be attributed to hematogenous viremia that has been shown to disseminate to virtually every organ.

Therapy included a 10-day course of intravenous acyclovir, intravenous corticosteroids, and supportive care. The serious multiorgan dysfunction improved, and the patient was released from the hospital after 2 weeks of treatment.

Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.